Vivani to start in-human trial for GLP-1 implant for treating obesity
The company plans to initiate a clinical trial in Australia for its six-month GLP-1 implant in obese or overweight patients in Q4 this year.
12 July 2024
12 July 2024
The company plans to initiate a clinical trial in Australia for its six-month GLP-1 implant in obese or overweight patients in Q4 this year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.